A randomized phase II study investigating cilengitide added to standard chemoradiotherapy in patients with newly diagnosed glioblastoma with unmethylated O-6-methylguanine-DNA methyltransferase (MGMT) gene promoter: Initial report of the CORE study

Nabors, Louis Burt; Fink, Karen L; Mikkelsen, Tom; Grujicic, Danica M; Tarnawski, Rafal; Nam, Do-Hyun; Perry, James R; Mazurkiewicz, Maria; Picard, Martin; Reardon, David A

Rezultati

eNauka > Rezultati > A randomized phase II study investigating cilengitide added to standard chemoradiotherapy in patients with newly diagnosed glioblastoma with unmethylated O-6-methylguanine-DNA methyltransferase (MGMT) gene promoter: Initial report of the CORE study

Naziv:	A randomized phase II study investigating cilengitide added to standard chemoradiotherapy in patients with newly diagnosed glioblastoma with unmethylated O-6-methylguanine-DNA methyltransferase (MGMT) gene promoter: Initial report of the CORE study
Autori:	Nabors, Louis Burt; Fink, Karen L; Mikkelsen, Tom; Grujicic, Danica M; Tarnawski, Rafal; Nam, Do-Hyun; Perry, James R; Mazurkiewicz, Maria; Picard, Martin; Reardon, David A
Godina:	2013
Publikacija:	EUROPEAN JOURNAL OF CANCER
ISSN:	0959-8049 European Journal of Cancer / EJC Pretraži identifikator
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 49 str. S17-S18
WoS-ID:	000209470600045
URI:	https://enauka.gov.rs/handle/123456789/831250
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

2
WEB OF SCIENCE^TM

Pronađi DOI

Pronalaženje DOI u servisu CrossRef-u na osnovu meta-podataka u zapisu. Prikazaće se DOI (i metapodaci) čiji se podaci najviše poklapaju. OPREZ - to ne mora biti ta publikacija.

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.